-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Surgery Partners, Lowers Price Target to $31

Benzinga·11/11/2025 15:28:20
Listen to the news
RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $35 to $31.